Loading...

Axsome Therapeutics, Inc.

AXSM•NASDAQ
Healthcare
Biotechnology
$185.96
$3.24(1.77%)
U.S. Market opens in 49h 27m

Axsome Therapeutics, Inc. (AXSM) Stock Overview

Explore Axsome Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap9.5B
P/E Ratio-51.82
EPS (TTM)$-3.69
ROE-2.54%
Fundamental Analysis

AI Price Forecasts

1 Month$142.27
3 Months$175.41
1 Year Target$170.02

AXSM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Axsome Therapeutics, Inc. (AXSM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 62.48, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $170.02.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -51.82 and a market capitalization of 9.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.77%
5-Day Change
-0.51%
1-Month Change
17.14%
3-Month Change
N/A
6-Month Change
43.54%
Year-to-Date (YTD) Change
1.82%
1-Year Change
76.42%
3-Year Change
153.63%
5-Year Change
216.74%
All-Time (Max) Change
2027.69%

Contact Information

https://www.axsome.com
212 332 3241
22 Cortlandt Street, New York City, NY, 10007

Company Facts

712 Employees
IPO DateNov 19, 2015
CountryUS
Actively Trading

Frequently Asked Questions